Dermata Therapeutics, Inc.
SEC CIK 1853816 · DRMA · last insider filing 2026-06-16
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Scott Kathleen D. | Director | filed 2021 - 2026 |
| Hale David F | Director | filed 2021 - 2026 |
| Wierenga Wendell | Director | filed 2021 - 2026 |
| Fisher Mary | Director | filed 2021 - 2026 |
| Proehl Gerald T | Director · President, CEO and Chairman | filed 2021 - 2026 |
| Mento Steven J | Director | filed 2021 - 2026 |
| Sandler Andrew Seth | Director | filed 2021 - 2026 |
| Bradrick Brittany | Director | filed 2022 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Bedoya-Toro Munera Maria E | Senior Vice President | filed 2021 - 2026 |
| Van Hoose Kyri K. | SVP, Chief Financial Officer | filed 2021 - 2026 |
| Nardo Christopher J. | Senior VP, Development | filed 2021 - 2026 |
| Insley Thomas | Chief Financial Officer | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.